TG THERAPEUTICS, INC. Property, Plant and Equipment
TG THERAPEUTICS, INC. (TGTX) had Property, Plant and Equipment of $66.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-06.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:PropertyPlantAndEquipmentNet · last filed 2024-05-06
- 2024-03-31: Property, Plant and Equipment, Net $66.00K.
- 2023-12-31: Property, Plant and Equipment, Net $95.00K.
- 2023-09-30: Property, Plant and Equipment, Net $133.00K.
- 2023-06-30: Property, Plant and Equipment, Net $206.00K.
| Period end | Property, Plant and Equipment, Net | Property, Plant and Equipment, Net as first filed |
|---|---|---|
| 2024-03-31 | $66.00K 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $95.00K 10-Q · filed 2024-05-06 | |
| 2023-09-30 | $133.00K 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $206.00K 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $237.00K 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $307.00K 10-K · filed 2024-02-29 | |
| 2022-09-30 | $376.00K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $447.00K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $526.00K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $600.00K 10-K · filed 2023-03-01 | |
| 2021-09-30 | $600.00K 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $597.00K 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $488.00K 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $481.00K 10-K · filed 2022-03-01 | |
| 2020-09-30 | $378.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $331.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $320.00K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $282.00K 10-K · filed 2021-03-01 | |
| 2019-09-30 | $275.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $237.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $241.00K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $251.00K 10-K · filed 2020-03-02 | |
| 2018-09-30 | $268.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $265.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $252.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $248.00K 10-K · filed 2019-03-01 | $248.02K 10-K · filed 2018-03-15 |
| 2017-09-30 | $268.37K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $289.31K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $307.73K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $328.15K 10-K · filed 2018-03-15 | |
| 2016-09-30 | $327.67K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $333.86K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $323.00K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $47.12K 10-K · filed 2017-03-16 | |
| 2015-09-30 | $69.22K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $34.83K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $24.82K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $20.36K 10-K · filed 2016-03-15 | |
| 2014-09-30 | $7.76K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $7.33K 10-Q · filed 2014-07-24 | |
| 2014-03-31 | $8.18K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $5.72K 10-K · filed 2015-03-16 | |
| 2013-09-30 | $3.83K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $2.53K 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $1.05K 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $1.16K 10-K · filed 2014-03-07 | |
| 2012-09-30 | $1.28K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $1.40K 10-Q/A · filed 2012-09-07 | |
| 2011-12-31 | $0.00 10-K · filed 2013-03-21 | |
| 2011-09-30 | $1.58K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $1.82K 10-Q/A · filed 2011-09-14 | |
| 2010-12-31 | $2.98K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |